We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
109 hedge funds and large institutions have $283M invested in Zevra Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
634% more call options, than puts
Call options by funds: $3.95M | Put options by funds: $539K
133% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 18
41% more capital invested
Capital invested by funds: $201M → $283M (+$81.9M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
8.52% more ownership
Funds ownership: 55.04% → 63.56% (+8.5%)
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
1% more funds holding
Funds holding: 108 → 109 (+1)
Holders
109
Holders Change
+1
Holders Change %
+0.93%
% of All Funds
1.44%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
25
Increased
42
Reduced
18
Closed
23
Calls
$3.95M
Puts
$539K
Net Calls
+$3.42M
Net Calls Change
-$1.43M
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$25.6M |
| 2 |
BlackRock
New York
|
+$8.18M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$6.73M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$5.09M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.41M |
Top Sellers
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$4.98M |
| 2 |
VPC
Vestal Point Capital
New York
|
-$3.64M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$2.68M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$2.43M |
| 5 |
Jane Street
New York
|
-$1.31M |
